公众号 / 文章技术与安全CTMR

欧盟AI法案第4条与第72条的放射实践解读

Article 4 and Article 72 in radiological practice: competence and surveillance beyond compliance.
PubMed 文献 · Eur J Radiol · 2026-07-08

本文解读欧盟人工智能法案中直接约束放射实践的第4条与第72条。第4条自2025年2月适用、2026年8月强制执行,要求提供方与部署方具备充分的AI素养。第72条要求对高风险AI系统实施全生命周期上市后监测,医疗AI相关要求将于2028年8月2日生效。

要点

  • 第4条是法律底线,应在其上构建可审计的AI能力框架。
  • 第72条应落实为类似药物警戒的临床监测文化架构。
  • 监测体系需包括本地漂移检测、亚组审计、公开报告与停机标准。

核心结论

  • 合规与文化的区分是欧洲放射学临床AI落地的操作前沿。
  • 两项转变在技术上并非新事物,其价值在于明确的监管锚定。

研究设计与样本

  • 本文为观点性论文,非监管法律评注。
  • 依据欧盟人工智能法案(Regulation (EU) 2024/1689)第4条与第72条条文及修订时间表展开论述。
  • 参考欧洲放射学界现有成果,包括ESR Essentials系列、ESR AI工作组声明、多学会联合声明、ESR上市后监测共识及一篇实施错误的叙述性综述。

诊断标准与关键数值

  • 第4条要求提供方与部署方具备充分的AI素养,自2025年2月起适用,2026年8月起强制执行。
  • 第72条要求对高风险AI系统建立覆盖全生命周期的上市后监测系统。
  • 医疗AI相关第72条要求按修订后的时间表于2028年8月2日生效。

临床应用与阅片要点

  • 放射科医师应经过培训,能够在自身人群部署的模型中主动识别失败模式,而非仅背诵失败模式清单。
  • 第72条不应只是提交给公告机构的文件化监测计划,而应构建临床监测文化架构。
  • 监测文化架构应类似药物警戒体系,包含连续本地漂移检测、亚组审计、公开报告与停机标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Two provisions of the EU Artificial Intelligence Act (Regulation (EU) 2024/1689) now reach into radiological practice. Article 4, applicable since February 2025 and enforced from August 2026, requires a sufficient level of AI literacy in providers and deployers. Article 72 will require a post-market monitoring system over the lifecycle of high-risk AI systems; for medical AI they are set to take effect on 2 August 2028 under the amended timeline. Current compliance framework: The European radiological community has responded with a coherent body of work: the ESR Essentials series, statements from the ESR AI Working Group and a multi-society coalition, the ESR post-market-surveillance consensus, and a recent narrative review of implementation errors.

ARGUMENT: This Opinion Paper is not a regulatory commentary. Two operational shifts are now due. First, Article 4 should be read as a floor - the legal minimum - over which an audit-capable competence framework is built: radiologists trained not to recite failure modes but to detect them in models deployed on their own population. Article 72 should be operationalized not as a documentary monitoring plan filed with notified bodies but as the architecture of a clinical surveillance culture analogous to pharmacovigilance, with continuous local drift detection, subgroup audit, public reporting, and shutdown criteria.

CONCLUSION: Neither shift is technically novel; their value lies in the explicit regulatory anchoring. The distinction between compliance and culture is the operational frontier of clinical AI in European radiology.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. García-Hidalgo. Article 4 and Article 72 in radiological practice: competence and surveillance beyond compliance. Eur J Radiol. 2026. PMID: 42435572. doi:10.1016/j.ejrad.2026.113058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。